PHARMACYTE BIOTECH, INC. Operating Leases, Rent Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Operating Leases, Rent Expense of $33.88 thousand for the 12-month period ending 2018-04-30, per its 10-K filed 2018-07-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2018-07-20
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for the quarter ending 2017-10-31 was $8.60K, a 10.17% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for the quarter ending 2017-07-31 was $8.22K, a 40.64% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for the quarter ending 2017-04-30 was $8.76K, a 10.24% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for the quarter ending 2017-01-31 was $13.70K, a 1.08% decline year-over-year.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for fiscal 2018 was $33.88K, a 26.18% decline from fiscal 2017.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for fiscal 2017 was $45.89K, a 13.78% decline from fiscal 2016.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for fiscal 2016 was $53.23K, a 8.07% increase from fiscal 2015.
- PHARMACYTE BIOTECH, INC. operating leases, rent expense for fiscal 2015 was $49.25K, a 0.34% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|
| 2018-04-30 | $33.88K 10-K · filed 2018-07-20 | ||||
| 2017-10-31 | $8.60K 10-Q · filed 2017-12-14 | $16.82K 10-Q · filed 2017-12-14 | $25.59K derived: sum of 3 quarters · filed 2018-07-20 | $39.29K derived: sum of 4 quarters · filed 2018-07-20 | |
| 2017-07-31 | $8.22K 10-Q · filed 2017-09-13 | $16.98K derived: sum of 2 quarters · filed 2018-07-20 | $30.68K derived: sum of 3 quarters · filed 2018-07-20 | $40.26K derived: sum of 4 quarters · filed 2018-07-20 | |
| 2017-04-30 | $8.76K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | $22.46K derived: sum of 2 quarters · filed 2018-07-20 | $32.04K derived: sum of 3 quarters · filed 2018-07-20 | $45.89K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $13.70K 10-Q · filed 2017-03-13 | $23.28K derived: sum of 2 quarters · filed 2017-12-14 | $37.13K 10-Q · filed 2017-03-13 | $46.89K derived: sum of 4 quarters · filed 2017-12-14 | |
| 2016-10-31 | $9.58K 10-Q · filed 2017-12-14 | $23.43K 10-Q · filed 2017-12-14 | $33.19K derived: sum of 3 quarters · filed 2017-12-14 | $47.04K derived: sum of 4 quarters · filed 2017-12-14 | |
| 2016-07-31 | $13.85K 10-Q · filed 2017-09-13 | $23.61K derived: sum of 2 quarters · filed 2017-09-13 | $37.47K derived: sum of 3 quarters · filed 2017-09-13 | $54.58K derived: sum of 4 quarters · filed 2017-09-13 | |
| 2016-04-30 | $9.76K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | $23.61K derived: sum of 2 quarters · filed 2017-07-27 | $40.73K derived: sum of 3 quarters · filed 2017-07-27 | $53.23K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $13.85K 10-Q · filed 2017-03-13 | $30.97K derived: sum of 2 quarters · filed 2017-03-13 | $43.46K 10-Q · filed 2017-03-13 | $57.32K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-10-31 | $17.11K 10-Q · filed 2016-12-02 | $29.61K 10-Q · filed 2016-12-02 | $43.47K derived: sum of 3 quarters · filed 2016-12-02 | $55.97K derived: sum of 4 quarters · filed 2016-12-02 | |
| 2015-07-31 | $15.01K 10-Q · filed 2016-09-06 | $12.50K 10-Q · filed 2015-08-25 | $26.36K derived: sum of 2 quarters · filed 2016-09-06 | $38.85K derived: sum of 3 quarters · filed 2016-09-06 | $52.13K derived: sum of 4 quarters · filed 2016-09-06 |
| 2015-04-30 | $11.35K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $23.84K derived: sum of 2 quarters · filed 2016-07-29 | $37.12K derived: sum of 3 quarters · filed 2016-07-29 | $49.25K 10-K · filed 2016-07-29 | |
| 2015-01-31 | $12.50K 10-Q · filed 2016-03-08 | $25.77K derived: sum of 2 quarters · filed 2016-03-08 | $37.91K 10-Q · filed 2016-03-08 | ||
| 2014-10-31 | $13.27K 10-Q/A · filed 2016-01-19 | $25.41K 10-Q/A · filed 2016-01-19 | |||
| 2014-07-31 | $12.13K 10-Q/A · filed 2016-01-19 | ||||
| 2014-04-30 | $49.09K 10-K · filed 2016-07-29 | ||||
| 2013-04-30 | $56.76K 10-K/A · filed 2016-01-19 | ||||
| 2012-04-30 | $41.82K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |